Frost & Sullivan 2026 Blue Book — Global AI Healthcare Industry Development
OVERVIEWFrost & Sullivan has published its 2026 Blue Book on the development of the global AI healthcare industry, providing a comprehensive market intelligence overview of investment trends, technology adoption curves, and regional growth dynamics. The report is positioned as a strategic planning resource for healthcare executives, investors, and technology vendors. The Blue Book examines AI adoption across major healthcare segments including diagnostics, clinical documentation, revenue cycle management, and drug discovery. It highlights the divergence in AI maturity between North American health systems—where enterprise deployment is accelerating—and emerging markets where infrastructure constraints remain a limiting factor. Regional analysis covers China, India, Southeast Asia, and the Middle East as high-growth AI healthcare markets, with particular attention to government-backed AI health initiatives. The report also addresses governance and regulatory readiness as a key differentiator between markets that will successfully scale AI and those that face adoption barriers. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.